Pharma IQ | 11/02/2010
Peter Schroeer, Director Europe, Quality Systems & Regulatory Affairs at Johnson & Johnson, speaks to Andrea Charles from Pharma IQ, about the current compliance challenges the medical device market faces and what impact the reuse warning statement requirement per directive 2007/47/EC has had on global labeling strategies. He also shares his top 3 tips for defining and implementing a global labeling strategy and his insights on what future global...
To continue reading this story Click Here
RECOMMENDED
Upcoming Events
DigIT Pharma AI Commercial Excellence & Health 2025
September 1 - 3, 2025
Palace Hotel Berlin, Germany
Register Now |
View Agenda |
Learn More
GenAI Life Science & Health 2025
September 1 - 3, 2025
Berlin, Germany
Register Now |
View Agenda |
Learn More